ADHD
Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.
CompletedNCT00782080
What is this study about?Researchers compared Sedariston and placebo, tracking side effects to assess safety in children and adolescents with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including AlzeyADHDMedication studyAges 6–17
- Countries
- Germany
- Sponsor
- Prof. Huss
CompletedNCT01536210
What is this study about?Researchers compared YY-162 and placebo to find out how the approaches affected ADHD symptoms in children with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including Anyang-siADHDMedication studyAges 6–15
- Countries
- South Korea
- Sponsor
- Yuyu Pharma, Inc.
CompletedNCT01201187
What is this study about?Researchers compared YY-162 and placebo to find out how the approaches affected ADHD symptoms in children with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including Anyang-siADHDMedication studyAges 6–12
- Countries
- South Korea
- Sponsor
- Yuyu Pharma, Inc.
CompletedNCT04860024
Official study titleThe Prospective Role of Epigenetics in Attention-deficit/Hyperactivity Disorderdeficit/Hyperactivity Disorder
This study has finished and is no longer accepting participants.
In Kaohsiung CityADHDObservational studyAges 6–12
- Countries
- Taiwan
- Sponsor
- Chang Gung Memorial Hospital
CompletedNCT00501293
What is this study about?Researchers studied Methylphenidate Transdermal System, tracking side effects to assess long-term safety in young people with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including ScottsdaleADHDMedication studyAges 13–17
- Countries
- United States
- Sponsor
- Noven Therapeutics
CompletedNCT05384717
Official study titleDo Fidget Instruments Enhance Attentional Control and Comprehension in 6-13 Year-olds With Attention Deficit Hyperactivity Disorder (ADHD)?
This study has finished and is no longer accepting participants.
In CaryADHDPlacebo comparisonAges 6–13
- Countries
- United States
- Sponsor
- University of North Carolina, Chapel Hill
CompletedNCT05016102
Official study titleDifferent Exercise Types on Inhibitory Control in Children With ADHD
This study has finished and is no longer accepting participants.
Location not clearly listedADHDInterventional studyAges 8–12
- Countries
- Sponsor
- National Taiwan Normal University
CompletedNCT04112758
Official study titleThe Effect of Long-term High-intensity Interval Training on Conflict Monitoring in Children With ADHD: an ERP and sLORETA Study
This study has finished and is no longer accepting participants.
In TaipeiADHDInterventional studyAges 7–12
- Countries
- Taiwan
- Sponsor
- National Taiwan Normal University
CompletedNCT05906485
Official study titleRandomized Controlled Trials of the Effects of Near-infrared Spectroscopy (fNIRS) Neurofeedback Training Coupled With Virtual Reality Technology in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
This study has finished and is no longer accepting participants.
In Hong KongADHDBehavioural studyAges 7–12
- Countries
- China
- Sponsor
- The University of Hong Kong
CompletedNCT05551689
Official study titleEvaluation of the Effectiveness of the FOCUS ADHD Mobile Health Platform in the Monitoring of Adults With Attention-Deficit/ Hyperactivity Disorder (ADHD)
This study has finished and is no longer accepting participants.
In Porto AlegreADHDMedication studyAges 18–45
- Countries
- Brazil
- Sponsor
- Hospital de Clinicas de Porto Alegre
CompletedNCT00046059
This study has finished and is no longer accepting participants.
Multiple locations, including OrangeADHDObservational studyAges 7–110
- Countries
- United States
- Sponsor
- National Human Genome Research Institute (NHGRI)